| Dr Bennett Sanford Romanoff, MD | |
|
4915 E Baseline Rd Ste 114, Gilbert, AZ 85234-2966 | |
| (480) 830-0120 | |
| (480) 994-9479 |
| Full Name | Dr Bennett Sanford Romanoff |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 50 Years |
| Location | 4915 E Baseline Rd Ste 114, Gilbert, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790784155 | NPI | - | NPPES |
| 0386667 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 35037662R (Ohio) | Secondary |
| 207W00000X | Ophthalmology | 62765 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Ophthalmologists Ltd | 8325024805 | 20 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Santa Clara-based Shastha Foods and the South Asian Heart Center at El Camino Hospital have announced they have collaborated to create newly formulated versions of the company's popular fresh, stone ground "dosa" batter using the Center's nutritional guidelines for healthy heart-savvy ingredients.
Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
The Ministry of Health, Labour and Welfare in Japan today approved dabigatran etexilate, Boehringer Ingelheim's novel, oral direct thrombin inhibitor under the brand name Prazaxa for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation marking the first approval of a novel oral anticoagulant in the Asia-Pacific region and specifically Japan in nearly 50 years.
› Verified 6 days ago
| Entity Name | Associated Ophthalmologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487704581 PECOS PAC ID: 8325024805 Enrollment ID: O20040625000445 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Santa Clara-based Shastha Foods and the South Asian Heart Center at El Camino Hospital have announced they have collaborated to create newly formulated versions of the company's popular fresh, stone ground "dosa" batter using the Center's nutritional guidelines for healthy heart-savvy ingredients.
Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
The Ministry of Health, Labour and Welfare in Japan today approved dabigatran etexilate, Boehringer Ingelheim's novel, oral direct thrombin inhibitor under the brand name Prazaxa for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation marking the first approval of a novel oral anticoagulant in the Asia-Pacific region and specifically Japan in nearly 50 years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bennett Sanford Romanoff, MD 2111 E Highland Ave Ste B-240, Phoenix, AZ 85016-4741 Ph: (480) 994-5012 | Dr Bennett Sanford Romanoff, MD 4915 E Baseline Rd Ste 114, Gilbert, AZ 85234-2966 Ph: (480) 830-0120 |
News Archive
Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.
Santa Clara-based Shastha Foods and the South Asian Heart Center at El Camino Hospital have announced they have collaborated to create newly formulated versions of the company's popular fresh, stone ground "dosa" batter using the Center's nutritional guidelines for healthy heart-savvy ingredients.
Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.
The Ministry of Health, Labour and Welfare in Japan today approved dabigatran etexilate, Boehringer Ingelheim's novel, oral direct thrombin inhibitor under the brand name Prazaxa for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation marking the first approval of a novel oral anticoagulant in the Asia-Pacific region and specifically Japan in nearly 50 years.
› Verified 6 days ago
Dr. Lawrence Stephen Kahn, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2450 E Guadalupe Rd, Ste 107, Gilbert, AZ 85234 Phone: 480-507-0600 Fax: 480-558-7162 | |
Dr. R Stuart Eason, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2450 E Guadalupe Rd, Ste 107, Gilbert, AZ 85234 Phone: 480-507-0600 Fax: 480-558-7162 | |
Dr. Trenton James Bowen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1760 E Pecos Rd Ste 201, Gilbert, AZ 85295 Phone: 480-590-2039 |